Abstract
A high performance liquid chromatography (HPLC) method for the determination of the monosaccharide compositions and molar ratio of polysaccharide in quince has been established. The quince polysaccharides were derivatized with 1-phenyl-3-methyl-5- pyrazolone (PMP) after hydrolyzed into monosaccharides with 2 M sulfuric acid. Monosaccharide derivatives were separated by a reversed phase C18 column and monitored by UV at 250 nm. Analysis of monosaccharides of quince polysaccharides sample by HPLC indicated the presence of mannose, rhamnose, glucose, galactose, and arabinose with the molar ratio of 0.10, 0.72, 1.12, 4.23, and 4.73, respectively. It could be applied for the quality control of quince polysaccharides. Moreover, quince polysaccharide shows the inhibitory activity of protein tyrosine phosphatase- 1B (PTP1B) with IC50 value of 2.07 μg/mL.
Keywords: Derivatization, high performance liquid chromatography, Analysis, 1-phenyl-3-methyl-5-pyrazolone, Polysaccharide of quince, protein tyrosine phosphatase-1B, Inhibitory activity, Hydrolysed, Monosaccharide composition, UV
The Natural Products Journal
Title: HPLC Analysis of Polysaccharides in Quince (Cydonia Oblonga Mill. var. maliformis) Fruit and PTP1B Inhibitory Activity
Volume: 1 Issue: 2
Author(s): Hajinisha Hopur, Akmal M. Asrorov, Ma Qingling, Ablimit Yili, Amatjan Ayupbek, Pang Nannan and Haji A. Aisa
Affiliation:
Keywords: Derivatization, high performance liquid chromatography, Analysis, 1-phenyl-3-methyl-5-pyrazolone, Polysaccharide of quince, protein tyrosine phosphatase-1B, Inhibitory activity, Hydrolysed, Monosaccharide composition, UV
Abstract: A high performance liquid chromatography (HPLC) method for the determination of the monosaccharide compositions and molar ratio of polysaccharide in quince has been established. The quince polysaccharides were derivatized with 1-phenyl-3-methyl-5- pyrazolone (PMP) after hydrolyzed into monosaccharides with 2 M sulfuric acid. Monosaccharide derivatives were separated by a reversed phase C18 column and monitored by UV at 250 nm. Analysis of monosaccharides of quince polysaccharides sample by HPLC indicated the presence of mannose, rhamnose, glucose, galactose, and arabinose with the molar ratio of 0.10, 0.72, 1.12, 4.23, and 4.73, respectively. It could be applied for the quality control of quince polysaccharides. Moreover, quince polysaccharide shows the inhibitory activity of protein tyrosine phosphatase- 1B (PTP1B) with IC50 value of 2.07 μg/mL.
Export Options
About this article
Cite this article as:
Hopur Hajinisha, M. Asrorov Akmal, Qingling Ma, Yili Ablimit, Ayupbek Amatjan, Nannan Pang and A. Aisa Haji, HPLC Analysis of Polysaccharides in Quince (Cydonia Oblonga Mill. var. maliformis) Fruit and PTP1B Inhibitory Activity, The Natural Products Journal 2011; 1 (2) . https://dx.doi.org/10.2174/2210315511101020146
DOI https://dx.doi.org/10.2174/2210315511101020146 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inflammasome as a New Therapeutic Target for Diabetic Complications
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Role of Intravenous Dihydropyridine Calcium Channel Blockers in the Perioperative Management of Patients Undergoing Coronary Artery Bypass Surgery
Current Vascular Pharmacology Recent Advances in the Oral Delivery of Insulin
Recent Patents on Drug Delivery & Formulation Immunoglobulin Free Light Chains in Immune Responses
Current Immunology Reviews (Discontinued) Imaging Subclinical Atherosclerosis: Where Do We Stand?
Current Cardiology Reviews Essential Fatty Acids - A Review
Current Pharmaceutical Biotechnology Five Years Patenting Time Frame Concerning Enzymatic Preparation of Glycosides
Recent Patents on Biotechnology Non-Analgesic Effects of Opioids: Opioid-induced Nausea and Vomiting: Mechanisms and Strategies for their Limitation
Current Pharmaceutical Design Phase 4 Studies in Heart Failure - What is Done and What is Needed?
Current Cardiology Reviews Targeting Chromatin Remodeling to Prevent Cardiovascular Disease in Diabetes
Current Pharmaceutical Biotechnology Pathophysiological Roles of Renin-Angiotensin System on Erythropoietic Action
Current Hypertension Reviews Autoimmune Channelopathies of the Nervous System
Current Neuropharmacology Current Treatment Strategies for Non-Alcoholic Fatty Liver Disease (NAFLD)
Current Drug Discovery Technologies First Autochthonous case of Emerged Zoonotic Cutaneous Leishmaniasis in Mazandaran Province, Northern Iran: kDNA-PCR Evidence Base
Infectious Disorders - Drug Targets Medication-Induced Nephrotoxicity in Older Patients
Current Drug Metabolism Pharmacological Properties and Therapeutic Potential of Naringenin: A Citrus Flavonoid of Pharmaceutical Promise
Current Pharmaceutical Design Editorial: Nailfold Capillaroscopy in Rheumatology
Current Rheumatology Reviews Novel Cardiovascular Risk Factors and Macrovascular and Microvascular Complications of Diabetes
Current Drug Targets Nanoemulsions: A Better Approach for Antidiabetic Drug Delivery
Current Diabetes Reviews CEST MRI for Molecular Imaging of Brain Metabolites
Current Molecular Imaging (Discontinued)